Blood Biomarkers of Uveal Melanoma: Current Perspectives

Manuel F Bande Rodríguez, 1, 2 Beatriz Fernandez Marta, 1 Nerea Lago Baameiro, 3 Maria Santiago-Varela, 1, 2 Paula Silva-Rodríguez, 2, 4 María Jose Blanco-Teijeiro, 1, 2 Maria Pardo Perez, 3 Antonio Piñeiro Ces 1, 2 1Unidad de Retina Quirúrgica...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Bande Rodríguez MF, Fernandez Marta B, Lago Baameiro N, Santiago-Varela M, Silva-Rodríguez P, Blanco-Teijeiro MJ, Pardo Perez M, Piñeiro Ces A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	serum biomarker uveal melanoma ophthalmology Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/51643df015ed40b9bd1349836152e92b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:51643df015ed40b9bd1349836152e92b
record_format	dspace
spelling	oai:doaj.org-article:51643df015ed40b9bd1349836152e92b2021-12-02T08:49:23ZBlood Biomarkers of Uveal Melanoma: Current Perspectives1177-5483https://doaj.org/article/51643df015ed40b9bd1349836152e92b2020-01-01T00:00:00Zhttps://www.dovepress.com/blood-biomarkers-of-uveal-melanoma-current-perspectives-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Manuel F Bande Rodríguez, 1, 2 Beatriz Fernandez Marta, 1 Nerea Lago Baameiro, 3 Maria Santiago-Varela, 1, 2 Paula Silva-Rodríguez, 2, 4 María Jose Blanco-Teijeiro, 1, 2 Maria Pardo Perez, 3 Antonio Piñeiro Ces 1, 2 1Unidad de Retina Quirúrgica y Tumores Intraoculares del Adulto (URQTIA), Servicio de Oftalmología Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, Santiago de Compostela, Spain; 2Tumores Intraoculares en el Adulto, Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain; 3Grupo Obesidómica, Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain; 4Fundación Pública Galega de Medicina Xenómica, Clinical University Hospital, SERGAS, Santiago de Compostela 15705, SpainCorrespondence: Manuel F Bande RodríguezUnidad de Retina Quirúrgica y Tumores Intraoculares del Adulto (URQTIA), Servicio de Oftalmología Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, Santiago de Compostela, SpainTel +34981951756Fax +34981956189Email verman017@hotmail.comAbstract: The detection of metastases in patients with a diagnosis of uveal melanoma (UM) is a controversial issue. While only 1% of the patients have detectable metastases at the time of diagnosis, up to 30% of them will develop liver metastases within 5 years of treatment. UM spreads hematogenously, therefore, blood biomarkers may be helpful for prognosis and monitoring the disease progression. Despite the great progress achieved thanks to the genetic analysis of UM biopsies, this is an invasive technique and is limited by the heterogeneity of the tumor. The present review considers the current understanding in the field regarding biomarkers for the diagnosis and prognosis of UM and its metastasis, primarily to the liver. General covered topics include non-conventional markers such as proteins previously identified in cutaneous melanoma and UM cell lines, circulating tumor cells, microRNAs (miRNA), and circulating DNA, and how each may be critical in the development of novel blood biomarkers for UM.Keywords: uveal melanoma, biomarker, circulating tumor cells, microRNAs, circulating DNA, exosomeBande Rodríguez MFFernandez Marta BLago Baameiro NSantiago-Varela MSilva-Rodríguez PBlanco-Teijeiro MJPardo Perez MPiñeiro Ces ADove Medical Pressarticleserum biomarkeruveal melanomaophthalmologyOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 14, Pp 157-169 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	serum biomarker uveal melanoma ophthalmology Ophthalmology RE1-994
spellingShingle	serum biomarker uveal melanoma ophthalmology Ophthalmology RE1-994 Bande Rodríguez MF Fernandez Marta B Lago Baameiro N Santiago-Varela M Silva-Rodríguez P Blanco-Teijeiro MJ Pardo Perez M Piñeiro Ces A Blood Biomarkers of Uveal Melanoma: Current Perspectives
description	Manuel F Bande Rodríguez, 1, 2 Beatriz Fernandez Marta, 1 Nerea Lago Baameiro, 3 Maria Santiago-Varela, 1, 2 Paula Silva-Rodríguez, 2, 4 María Jose Blanco-Teijeiro, 1, 2 Maria Pardo Perez, 3 Antonio Piñeiro Ces 1, 2 1Unidad de Retina Quirúrgica y Tumores Intraoculares del Adulto (URQTIA), Servicio de Oftalmología Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, Santiago de Compostela, Spain; 2Tumores Intraoculares en el Adulto, Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain; 3Grupo Obesidómica, Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain; 4Fundación Pública Galega de Medicina Xenómica, Clinical University Hospital, SERGAS, Santiago de Compostela 15705, SpainCorrespondence: Manuel F Bande RodríguezUnidad de Retina Quirúrgica y Tumores Intraoculares del Adulto (URQTIA), Servicio de Oftalmología Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, Santiago de Compostela, SpainTel +34981951756Fax +34981956189Email verman017@hotmail.comAbstract: The detection of metastases in patients with a diagnosis of uveal melanoma (UM) is a controversial issue. While only 1% of the patients have detectable metastases at the time of diagnosis, up to 30% of them will develop liver metastases within 5 years of treatment. UM spreads hematogenously, therefore, blood biomarkers may be helpful for prognosis and monitoring the disease progression. Despite the great progress achieved thanks to the genetic analysis of UM biopsies, this is an invasive technique and is limited by the heterogeneity of the tumor. The present review considers the current understanding in the field regarding biomarkers for the diagnosis and prognosis of UM and its metastasis, primarily to the liver. General covered topics include non-conventional markers such as proteins previously identified in cutaneous melanoma and UM cell lines, circulating tumor cells, microRNAs (miRNA), and circulating DNA, and how each may be critical in the development of novel blood biomarkers for UM.Keywords: uveal melanoma, biomarker, circulating tumor cells, microRNAs, circulating DNA, exosome
format	article
author	Bande Rodríguez MF Fernandez Marta B Lago Baameiro N Santiago-Varela M Silva-Rodríguez P Blanco-Teijeiro MJ Pardo Perez M Piñeiro Ces A
author_facet	Bande Rodríguez MF Fernandez Marta B Lago Baameiro N Santiago-Varela M Silva-Rodríguez P Blanco-Teijeiro MJ Pardo Perez M Piñeiro Ces A
author_sort	Bande Rodríguez MF
title	Blood Biomarkers of Uveal Melanoma: Current Perspectives
title_short	Blood Biomarkers of Uveal Melanoma: Current Perspectives
title_full	Blood Biomarkers of Uveal Melanoma: Current Perspectives
title_fullStr	Blood Biomarkers of Uveal Melanoma: Current Perspectives
title_full_unstemmed	Blood Biomarkers of Uveal Melanoma: Current Perspectives
title_sort	blood biomarkers of uveal melanoma: current perspectives
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/51643df015ed40b9bd1349836152e92b
work_keys_str_mv	AT banderodriguezmf bloodbiomarkersofuvealmelanomacurrentperspectives AT fernandezmartab bloodbiomarkersofuvealmelanomacurrentperspectives AT lagobaameiron bloodbiomarkersofuvealmelanomacurrentperspectives AT santiagovarelam bloodbiomarkersofuvealmelanomacurrentperspectives AT silvarodriguezp bloodbiomarkersofuvealmelanomacurrentperspectives AT blancoteijeiromj bloodbiomarkersofuvealmelanomacurrentperspectives AT pardoperezm bloodbiomarkersofuvealmelanomacurrentperspectives AT pineirocesa bloodbiomarkersofuvealmelanomacurrentperspectives
_version_	1718398360607522816

Blood Biomarkers of Uveal Melanoma: Current Perspectives

Ejemplares similares